These findings highlight that post-translational modifications, such as lysine lactylation and deubiquitination, are critical for PHI-1 stability and function, directly influencing cancer cell proliferation, metastasis, and drug resistance, making them potential targets for therapeutic intervention. The gene discussed is PPP1R14B; the disease is cancer.